2020. Venous thromboembolic diseases (NICE)
This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It supports rapid diagnosis and effective treatment for DVT or PE. It also covers testing for conditions that predispose to VTE such as thrombophilia and cancer.
2019. Diagnosis and management of acute pulmonary embolism (ESC/ERS)
Guidelines on the diagnosis and management of acute pulmonary embolism from the European Society of Cardiology (ESC) endorsed by the European Respiratory Society (ERS)
2018. Initial outpatient management of pulmonary embolism (BTS)
Patients with PE should be assessed for suitability for management as outpatients (OPs). Patients assessed as low risk and suitable for OP management should be offered treatment in an OP setting where a robust pathway exists for follow-up and monitoring.
2016. Antithrombotic Therapy for VTE Disease (ACCP)
For VTE and no cancer, as long-term anticoagulant therapy, we suggest dabigatran, rivaroxaban, apixaban, or edoxaban over vitamin K antagonist (VKA) therapy, and suggest VKA therapy over low-molecular-weight heparin. For VTE and cancer, we suggest LMWH over VKA,
dabigatran, rivaroxaban, apixaban, or edoxaban.
2013. Quality standard for venous thromboembolic diseases (NICE)
U.K. National Institute for health and clinical excellence quality standard covering the diagnosis and treatment of venous thromboembolic diseases in adults, excluding pregnant women.
2013. Venous Thromboembolism Diagnosis and Treatment (ICSI)
Institute for clinical systems improvement Healthcare Guideline on Venous Thromboembolism Diagnosis and Treatment
2012. Venous thromboembolic diseases (NICE)
National Institute for health and clinical excellence (NICE) clinical guideline on Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing covers diagnostic tests for initial assessment of suspected VTE and interventions to manage venous thromboembolic diseases.
2012. Antithrombotic Therapy and Prevention of Thrombosis (ACCP)
American College of Chest Physicians Evidence-Based Clinical Practice Guidelines on Antithrombotic Therapy and Prevention of Thrombosis
2011. PE, DVT and Chronic Thromboembolic Pulmonary Hypertension (AHA)
This scientific statement from the American Heart Association (AHA) provides evidence based recommendations for the management of patients with massive and submassive pulmonary embolism (PE), iliofemoral deep vein thrombosis (DVT), and chronic thromboembolic pulmonary hypertension (CTEPH).
2010. Venous Thromboembolism – reducing the risk in patients admitted to hospital (NICE)
Evidence based guidelines produced by the National Institute of Clinical Excellence (UK) on reducing the risk of Venous Thromboembolim, (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Includes ten key priorities for implementation including assessing all patients on admission to identify those who are at increased risk of venous thromboembolism.
2011. Evaluation of Suspected Pulmonary Embolism in Pregnancy (ATS)
An Official American Thoracic Society/Society of Thoracic Radiology Clinical Practice Guideline: Evaluation of Suspected Pulmonary Embolism In Pregnancy